Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

       
Total article views   HTML views PDF downloads Totals
12,640 Dovepress* 11,368+ 1,751 13,119
PubMed Central* 1,272 494 1,766
Totals 12,640 2,245 14,885
*Since 16 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar